WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H527845
CAS#: 39740-30-2 (HCl)
Description: Etilevodopa HCl is a prodrug of levodopa with greater gastric solubility and significant brain penetration.
Hodoodo Cat#: H527845
Name: Etilevodopa HCl
CAS#: 39740-30-2 (HCl)
Chemical Formula: C11H16ClNO4
Exact Mass: 261.08
Molecular Weight: 261.702
Elemental Analysis: C, 50.49; H, 6.16; Cl, 13.55; N, 5.35; O, 24.45
Related CAS #: 39740-30-2 (HCl) 37178-37-3 (free base)
Synonym: Etilevodopa HCl; L-Dopa ethyl ester; Levodopa ethyl ester; O-Ethyl-DOPA;
IUPAC/Chemical Name: 3,4-Dihydroxy-L-phenylalanine Ethyl Ester Hydrochloride
InChi Key: CVQFXVIIFKVRCK-QRPNPIFTSA-N
InChi Code: InChI=1S/C11H15NO4.ClH/c1-2-16-11(15)8(12)5-7-3-4-9(13)10(14)6-7;/h3-4,6,8,13-14H,2,5,12H2,1H3;1H/t8-;/m0./s1
SMILES Code: N[C@@H](CC1=CC=C(O)C(O)=C1)C(OCC)=O.[H]Cl
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 261.70 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2003 Apr;25(3):225-48. Review. PubMed PMID: 12743628.